Nutritional hepatic iron overload is not prevented by parenteral hepcidin
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F12%3A00009832" target="_blank" >RIV/00023736:_____/12:00009832 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1017/S0007114512000116" target="_blank" >http://dx.doi.org/10.1017/S0007114512000116</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1017/S0007114512000116" target="_blank" >10.1017/S0007114512000116</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Nutritional hepatic iron overload is not prevented by parenteral hepcidin
Popis výsledku v původním jazyce
The peptide hormone hepcidin functions as a negative regulator of intestinal Fe absorption and Fe recycling. Since its discovery as a systemic negative regulator of Fe metabolism, hepcidin has attracted enormous interest as a potential drug for the treatment and/or prevention of several forms of Fe overload. We therefore tested whether multiple doses of intraperitoneally administered synthetic renatured hepcidin can prevent hepatic Fe loading in mice concurrently fed an Fe-rich diet, and whether the same treatment affects hepatic Fe stores in mice fed a normal diet. Cohorts of male mice were fed either a normal defined diet (180parts per million Fe) or an Fe-rich diet (the same diet supplemented with 2% carbonyl iron for 2 weeks). Concurrently, half ofthe animals in each diet group received 100 ?g of renatured hepcidin intraperitoneally every 12h, for the same 2-week period. The second half of the animals received PBS only. The renatured synthetic hepcidin demonstrated biological acti
Název v anglickém jazyce
Nutritional hepatic iron overload is not prevented by parenteral hepcidin
Popis výsledku anglicky
The peptide hormone hepcidin functions as a negative regulator of intestinal Fe absorption and Fe recycling. Since its discovery as a systemic negative regulator of Fe metabolism, hepcidin has attracted enormous interest as a potential drug for the treatment and/or prevention of several forms of Fe overload. We therefore tested whether multiple doses of intraperitoneally administered synthetic renatured hepcidin can prevent hepatic Fe loading in mice concurrently fed an Fe-rich diet, and whether the same treatment affects hepatic Fe stores in mice fed a normal diet. Cohorts of male mice were fed either a normal defined diet (180parts per million Fe) or an Fe-rich diet (the same diet supplemented with 2% carbonyl iron for 2 weeks). Concurrently, half ofthe animals in each diet group received 100 ?g of renatured hepcidin intraperitoneally every 12h, for the same 2-week period. The second half of the animals received PBS only. The renatured synthetic hepcidin demonstrated biological acti
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2012
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
British journal of nutrition
ISSN
0007-1145
e-ISSN
—
Svazek periodika
108
Číslo periodika v rámci svazku
10
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
3
Strana od-do
1723-1725
Kód UT WoS článku
000311399400001
EID výsledku v databázi Scopus
—